Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Fesoterodine (Primary)
- Indications Urinary incontinence
- Focus Therapeutic Use
- Acronyms URGE
- 17 Feb 2017 Planned End Date changed from 1 May 2016 to 1 Dec 2017.
- 17 Feb 2017 Planned primary completion date changed from 1 May 2016 to 1 Dec 2017.
- 17 Feb 2017 Status changed from completed to active, no longer recruiting.